KATHRYN JACK: Open Payments
NPI 1265456347 · MERIDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,155 in 63 payments from 10 companies in 2025. Trend: 2023 $13,165 · 2024 $15,978 · 2025 $20,155
Speaker / faculty: $9,545Consulting: $5,470Food & beverage: $2,582Travel & lodging: $2,558
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 30 | $12,191 |
| Gilead Sciences, Inc. | 7 | $4,105 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $2,208 |
| Lilly USA, LLC | 1 | $900 |
| ABBVIE INC. | 6 | $288 |
| Phathom Pharmaceuticals, Inc. | 4 | $278 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| Ardelyx, Inc. | 3 | $56 |
| Janssen Biotech, Inc. | 1 | $29 |
| VIVUS LLC | 1 | $15 |
Products named: REZDIFFRA, Epclusa, TRULANCE, Livdelzi, OMVOH, VOQUEZNA, SKYRIZI, ENTYVIO.
Industry payments across CT — which companies pay providers there.
